
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Balversa is suitable for treating adult patients with locally advanced or metastatic urothelial carcinoma.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:320
Stiripentol is suitable for treating epileptic seizures associated with Dravet syndrome (DS).【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:297
Used for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults and children aged 6 months and older.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:319
Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:231
Lenvatinib is indicated for differentiated thyroid carcinoma (DTC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and endometrial carcinoma (EC).【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:80
Tucatinib can be used to treat breast cancer and colorectal cancer in adult patients.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:227
Vigabatrin is an adjuvant therapy for refractory complex partial epilepsy patients aged 2 years and above.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:208
Entrectinib is a Broad-spectrum antitumor agents.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:91
Upadacitinib can regulate abnormal immune responses, alleviate inflammation and symptoms of diseases.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:142
Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more previous systemic treatments.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:212
Adult patients with locally advanced or metastatic ROS1 positive non-small cell lung cancer (NSCLC).【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:272
Non small cell lung cancer with MET gene exon 14 mutation positive and unresectable progression and recurrence.【more】
Article source:Captain MedicineRelease date:2026-01-05Recommended:241
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:8542025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:10542024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended:3462026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:4202026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:6192026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:6042026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:4752026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:6222026-31-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643